Arrakis Therapeutics
banner
arrakistx.bsky.social
Arrakis Therapeutics
@arrakistx.bsky.social
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients.
Today, we join the world in recognizing UNESCO World #ScienceDay. This year’s theme: ‘Trust, Transformation, and Tomorrow: The Science We Need for 2050’ makes us excited about our mission to change the way challenging diseases are treated. #ExpeditionRNA
Learn more: www.unesco.org/en/days/scie...
November 10, 2025 at 2:44 PM
We recognize #InternationalPronounsDay today, in keeping with our core value of Being Human. We affirm the respect and human dignity of referring to people by their chosen pronouns.

Learn more: pronouns.org

#DareToBeArrakeen
October 15, 2025 at 1:30 PM
Today we honor Indigenous Peoples’ Day, recognizing and celebrating Indigenous American peoples and commemorating their histories and cultures. We acknowledge those that originally called this land their home. #IndigenousPeoplesDay
October 13, 2025 at 6:52 PM
It’s #NationalHispanicHeritageMonth Sept 15-Oct 15, and we’re proud to celebrate the culture and achievements of the Hispanic and Latino communities.

Learn more:
hispanicheritagemonth.gov/index.html
October 2, 2025 at 2:57 PM
Last week, we wore green for International #myotonicDystrophyAwareness Day (9/15) to raise awareness of the most common form of adult muscular dystrophy. We're developing an RNA-targeted small molecule drug program to treat myotonic dystrophy type 1 (DM1).
#myotonicDystrophy
September 26, 2025 at 2:23 PM
The Arrakis team gathered to volunteer at Waltham Fields Community Farm, helping with weeding and preparing their fall harvests. We’re glad to support the Farm, its educational programs, and the food it produces for the Waltham community.

#ArrakeensInAction
September 26, 2025 at 2:17 PM
At the Discovery on Target: RNA and DNA Targeting Small Molecule Drugs conference in Boston today, Emily, Associate Director, Medicinal Chemistry, presents on our proprietary platform to develop RNA-targeted small molecule (rSMs) medicines.

#ArrakeensInAction
September 23, 2025 at 12:58 PM
Monday at the HBM Biopharma Summit 2025 in Zurich, our Chief Business Officer James Mutamba will give a corporate presentation and Arrakis overview.

#ExpeditionRNA
September 19, 2025 at 1:58 PM
Our CEO Michael Gilman will share his experiences and discuss what it takes to scale innovation for lasting impact during a fireside chat today at the BioPort Atlantic 2025 conference in Halifax.

#ExpeditionRNA
September 17, 2025 at 1:29 PM
Proud to join the Myotonic Dystrophy Foundation as a Global Alliance member! We'll help raise awareness on International #myotonicDystrophyAwareness Day, on Monday 9/15. Our lead program: an RNA-targeted small molecule drug for the treatment of myotonic dystrophy type 1 (DM1). #myotonicDystrophy
September 12, 2025 at 1:24 PM
At the Computational Medicinal Chemistry School hosted by Novartis today in Cambridge, Aaron, Director of Computational Chemistry, shares his expertise on biomolecular modeling. #drugdiscovery #ArrakeensInAction
September 11, 2025 at 1:26 PM
Today we celebrate #WomensEquality Day, recognizing the day in 1920 when women were guaranteed the right to vote. Supporting equality in all its forms aligns with our core value of being human.

#WeAreArrakeen
August 26, 2025 at 1:55 PM
Our CBO James Mutamba is a “Tide Talk” speaker at the Nucleate Global Summit on Monday, joining a panel to discuss life science career transitions into pharma.

nucleate.org/summit_2024/...
August 15, 2025 at 5:42 PM
To celebrate #RNADay at Arrakis, we constructed our own ‘Arrakis RNA’ made with RNA codons that translate into amino acids that represent us, whether it be one of our initials or our favorite letter, and what we can create as a team!

#ExpeditionRNA #WeAreArrakeen
August 5, 2025 at 1:55 PM
Happy #RNADay! Today we celebrate all things RNA, the foundation of our mission to create rSMs (RNA-targeted small molecules) that act directly on RNA to treat disease.

#ExpeditionRNA
August 1, 2025 at 1:28 PM
Today our Founder and CSO Jennifer Petter, PhD joins other inspiring panelists to discuss leading with confidence and authenticity at a Harvard course for LGBTQ+ professionals.
#ArrakeensInAction
July 30, 2025 at 1:48 PM
We’re thankful as we celebrate July 4th tomorrow, recognizing the unique promise of our country and the importance of personal freedoms. We’re also proud to be based in the state where our independence was born. #WeAreArrakeen
July 3, 2025 at 1:23 PM
Last week we joined Xilio Therapeutics and Q32 Bio to celebrate #PrideMonth with our Waltham Biotech Pride Mix & Mingle, and we collected donations of essential items for The Waltham House LGBTQ+ youth group home.
Learn more: www.thehome.org/programs/wal...
#ArrakeensInAction
June 30, 2025 at 5:06 PM
Two Arrakeens are sharing their expertise at the 5th Annual Induced Proximity-Based Drug Discovery Summit in San Diego this week. Craig presents on our work targeting RNA, and Aaron leads a workshop on AI-driven co-folding. #ArrakeensInAction
June 25, 2025 at 2:02 PM
A team of Arrakeens participated in the J.P. Morgan Corporate Challenge this week for the annual 3.5-mile road race. We were proud to run in support of the Ron Burton Training Village, whose mission is to train youth to achieve their purpose with a range of programs. #ArrakeensInAction #JPMCC
June 20, 2025 at 6:50 PM
We recognize #Juneteenth today and honor the annual commemoration of the end of slavery. We’re taking the holiday today to reflect on the importance of this milestone to our country.

#WeAreArrakeen
June 19, 2025 at 1:45 PM
This week we were pleased to welcome SpeakOUT Boston for a #PrideMonth Lunch & Learn. The panel explored topics such as LGBTQ+ workplace issues, queer youth, gender identity, and allyship. Special thanks to our Pride Month planning committee for organizing this event. #Pride2025
June 18, 2025 at 5:55 PM
It’s #ImmigrantHeritageMonth, and we are proud of our backgrounds and the cultural diversity on #ExpeditionRNA.

We recognize the important role that immigrants play in our success at Arrakis and our communities. #DareToBeArrakeen
June 10, 2025 at 1:58 PM
At the 2nd Structure-Based Drug Discovery Summit tomorrow, Elena Menichelli, PhD, Director, Structural Biology, will present, discussing the challenges in generating high-resolution structures of RNA/ligand complexes and our work at Arrakis developing RNA-targeted small molecule (rSMs) medicines.
June 4, 2025 at 4:22 PM
As Pride Month begins, we focus on our core values of Being Human and Thriving as a Team, doubling down on our recognition of and honor for all LGBTQ+ people and the diversity they bring to both Arrakis and the world, making our communities stronger.

#Pride2025
June 2, 2025 at 6:50 PM